Drug intelligence / Profile preview

Bayovac SRS

Development stage
Unknown
Lead developer
Diversa
Modality
Vaccines & Immunotherapeutics
Administration
Intraperitoneal
01

Overview

Bayovac SRS is an inactivated veterinary vaccine (bacterin) developed for the aquaculture industry to protect salmonid fish against Salmon Rickettsial Septicaemia (SRS), a severe systemic disease caused by the Gram-negative intracellular bacterium *Piscirickettsia salmonis*. SRS is a major cause of mortality in farmed salmon, particularly in the Chilean aquaculture sector. The vaccine works by inducing active immunization through the presentation of inactivated bacterial antigens, which stimulates the production of specific antibodies and primes the cellular immune response. Originally developed by Bayer Animal Health, the product is typically administered via intraperitoneal injection to provide long-lasting protection during the seawater growth phase of the fish.

Brand names
Bayovac SRS
Other names
Piscirickettsia salmonis vaccine
02

Targets

Piscirickettsia salmonis

Beyond the preview

Go deeper on Bayovac SRS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bayovac SRS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call